$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
赞可达纳入医保目录了吗?
2025-10-19 11:44:20
Check Details
赞可达是哪产的?
2025-10-19 11:44:20
Check Details
赞可达对肺癌能有多大效果?
2025-10-19 11:44:20
Check Details
赞可达需要注意的事项有什么?
2025-10-19 11:44:20
Check Details
赞可达获批适应症有哪些?
2025-10-19 11:44:20
Check Details
赞可达哪里生产的?
2025-10-19 11:44:20
Check Details
赞可达在什么时候上市?
2025-10-19 11:44:20
Check Details
赞可达去哪可以买到?
2025-10-19 11:44:20
Check Details
Repotrectinib(洛普替尼)客观缓解令人鼓舞,FDA 对中期疗效做出回应
2025-10-19 11:44:20
Check Details
Sintilimab加化学疗法可改善晚期NSCLC的无进展生存期
2025-10-19 11:44:20
Check Details
FDA批准新类型培美曲塞用于非鳞状非小细胞肺癌
2025-10-19 11:44:20
Check Details
Lorbrena售价多生一盒?
2025-10-19 11:44:20
Check Details
1
2
...
3551
3552
3553
3554
3555
3556
3557
...
4153
4154
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Complete Guide to Dosage and Dose Adjustment of Entrectinib
2
Comprehensive Analysis of Bleeding Risk with Tepotinib in MET-Mutated Non-Small Cell Lung Cancer
3
Lomustine vs Temozolomide: Comprehensive Comparison of Efficacy and Safety in Glioma Treatment
4
Tepotinib and Osimertinib: Current Status and Clinical Positioning of Combination Therapy in Non-Small Cell Lung Cancer
5
Tumor Shrinkage Effect and Core Therapeutic Value of Pazopanib
6
Tabrecta (Capmatinib): A Targeted Therapy for METex14-Mutated NSCLC
7
Pazopanib Shows Promise as Second-Line Therapy for Aggressive Skin Cancer
8
Managing Immunotherapy-Related Adverse Events of Tarlatamab-Imdelltra: A Guide to Dual-Specific T Cell Engager Safety
9
Almonertinib Safety Guide: Managing Adverse Reactions in NSCLC Treatment with a 3rd-Gen EGFR TKI
10
Pimitespib Storage Guidelines: Temperature, Humidity & Light Control for Home Use
11
Cemiplimab (Libtayo) Drug Information
12
Mirvetuximab Soravtansine (Elahere): FRα-Targeted ADC for Platinum-Resistant Ovarian Cancer